“Impact of Infections in Patients With Acute Myeloid Leukemia Receiving Cytarabine+ Daunorubicin (7+3) Versus Azacitidine and Venetoclax During Induction Chemotherapy”. Indus Journal of Bioscience Research 3, no. 1 (January 10, 2025): 190–196. Accessed August 14, 2025. https://ijbr.com.pk/IJBR/article/view/469.